Novamin



Indications and Reactions:

Role Indications Reactions
Secondary
Pain 18.7%
Drug Use For Unknown Indication 10.1%
Product Used For Unknown Indication 8.0%
Nausea 7.4%
Cancer Pain 6.4%
Prophylaxis 6.1%
Spinal Column Stenosis 4.9%
Colorectal Cancer Metastatic 4.3%
Rheumatoid Arthritis 4.0%
Chronic Myeloid Leukaemia 3.1%
Constipation Prophylaxis 3.1%
Dizziness 3.1%
Hyperuricaemia 3.1%
Lumbar Spinal Stenosis 3.1%
Hepatic Neoplasm Malignant 2.8%
Constipation 2.5%
Metastases To Bone 2.5%
Periarthritis 2.5%
Restlessness 2.5%
Analgesia 2.1%
Systemic Inflammatory Response Syndrome 10.9%
Toxic Epidermal Necrolysis 9.1%
Vomiting 9.1%
Rash 7.3%
Malaise 5.5%
Off Label Use 5.5%
Somnolence 5.5%
Thrombocytopenia 5.5%
Treatment Noncompliance 5.5%
White Blood Cell Count Decreased 5.5%
Condition Aggravated 3.6%
Dizziness 3.6%
Gait Disturbance 3.6%
Hepatic Function Abnormal 3.6%
Inappropriate Schedule Of Drug Administration 3.6%
Nausea 3.6%
Salivary Hypersecretion 3.6%
Back Pain 1.8%
Dehydration 1.8%
Headache 1.8%
Concomitant
Prophylaxis 15.4%
Cancer Pain 13.2%
Pain 9.3%
Product Used For Unknown Indication 7.9%
Drug Use For Unknown Indication 7.3%
Constipation 7.2%
Nausea 5.4%
Hypertension 4.5%
Metastatic Renal Cell Carcinoma 4.0%
Insomnia 3.6%
Renal Cell Carcinoma 3.2%
Multiple Myeloma 3.0%
Prophylaxis Of Nausea And Vomiting 2.8%
Breast Cancer 2.5%
Metastases To Bone 2.4%
Gastritis Prophylaxis 1.9%
Prostate Cancer Stage Iv 1.8%
Gastritis 1.7%
Chemotherapy 1.5%
Pleural Mesothelioma Malignant 1.5%
White Blood Cell Count Decreased 14.4%
Vomiting 10.1%
Pyrexia 9.7%
Platelet Count Decreased 6.1%
Pneumonia 6.1%
Renal Impairment 5.9%
Interstitial Lung Disease 5.7%
Renal Cell Carcinoma 4.2%
Somnolence 4.2%
Nausea 4.0%
Wrong Technique In Drug Usage Process 4.0%
Prostate Cancer 3.4%
Malignant Neoplasm Progression 3.2%
Thrombocytopenia 3.2%
Liver Disorder 3.0%
Tumour Lysis Syndrome 3.0%
Sepsis 2.5%
Stomatitis 2.5%
Pain 2.3%
Pneumonia Aspiration 2.3%
Interacting
Hypertension 40.0%
Hyperlipidaemia 20.0%
Pyrexia 20.0%
Upper Respiratory Tract Infection 20.0%
Upper Respiratory Tract Infection 100.0%